Roflumilast CAS 162401-32-3 Assay 99.0~101.0% API
Ruifu Chemical Supply Roflumilast Intermediates:
Roflumilast CAS 162401-32-3
4-Amino-3,5-Dichloropyridine CAS 22889-78-7
Lebitso la Lik'hemik'hale | Roflumilast |
Litlhaloso tse tšoanang | 3-(Cyclopropylmethoxy)-N-(3,5-Dichloropyridin-4-yl)-4-(Ddifluoromethoxy)benzamide |
Nomoro ea CAS | 162401-32-3 |
Nomoro ea KAtse | RF-PI2075 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C17H14Cl2F2N2O3 |
Boima ba Molek'hule | 403.21 |
Botenya | 1.471±0.060 g/cm3 |
Kutloisiso | Mocheso o Mamela |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo ea Crystalline e tšoeu kapa e batlang e le tšoeu |
Solubility | E qhibiliha ka har'a acetone, e qhibiliha hanyenyane ka har'a acetronitrile, e sa qhibilihe hanyenyane ka ethanol ea anhydrous, e batlang e sa qhibilihe metsing. |
Melting Point | 157.0 ~ 162.0℃ |
Tahlehelo ka ho Omisa | <0.50% |
Masalla a ho Ignition | ≤0.10% |
Litšepe tse boima | ≤10ppm |
Chloride | ≤0.01% |
Boitsebiso ba A. UV | Bophahamo ba maqhubu a ho monya ho lokela ho ba ho 213 ~ 251nm |
Boitsebiso B. IR | Sekhahla sa ho monya sa IR sa sampole se lumellana le sa referense |
Boitsebiso C. | E bontša karabelo ea Fluoride |
Lintho Tse Amanang | |
Tšilafalo e le Mong | ≤0.10% |
Litšila ka Kakaretso | <0.50% |
Metsoako e setseng | |
Tert-Butanol | <0.10% |
Tetrahydrofuran | <0.072% |
Toluene | <0.089% |
N, N-Dimethylformamide | <0.088% |
Tlhahlobo | 99.0 ~ 101.0% (E baloa ka Motheo o Omisitsoeng) |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | API;COPD |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
Roflumilast (CAS: 162401-32-3) ke khetho ea oral phosphodiesterase-4 (PDE-4) inhibitor le motsoako oa benzamide.E ntlafalitsoe ke k'hamphani ea Jeremane ea Altana ka 1993 'me ke eona feela inhibitor ea molomo ea PDE-4 e sebelisoang ho phekola mafu a phefumoloho a lumelletsoeng ho rekisoa.Roflumilast ke setlhare sa pele sa mofuta oa sona se lebisang lefung le matla le sa foleng le sa foleng la matšoafo (COPD), hape ke setlhare sa pele sa molomo se khahlanong le ho ruruha se etselitsoeng bakuli ba COPD.Thepa ea eona e ikhethang e ka thusa ho laola COPD: ha e sebelisoa hammoho le li-bronchodilator ho phekola bakuli ba matla haholo ba COPD, Roflumilast e ka ba le monyetla oa ho fokotsa matšoao le sekhahla sa ho senyeha, kahoo e etsa hore e be moriana oa pele o lebisitseng ho bakuli ba nang le phenotype-spAecific COPD e ntseng e senyeha khafetsa. le tšitiso e matla ea moea e amanang le ho khohlela ho sa foleng le phlegm e feteletseng.Ntle le ho ba kalafo ea COPD e matla, Roflumilast e ka boela ea sebelisoa ho thibela le ho alafa mafu a phefumoloho ea mehlape, sefuba se feteletseng sa bronchitis, bronchitis ea asthmatic, le bronchitis e matla le sacculitis ea moea e tsamaeang le secretion e sa tloaelehang ea phefumoloho.